Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cai Grau

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2024
Comprehensive insights on the underlying potential and advantage of proton therapy over intensity-modulated photon radiation therapy as highlighted in a wide real world data analysisEster Orlandi, Giulia Fontana, Lisa Licitra, et al.
The Lancet. Oncology|February 5, 2019
Towards an evidence-informed value scale for surgical and radiation oncology: a multi-stakeholder perspectiveYolande Lievens, Riccardo Audisio, Ian Banks, et al.
The Lancet. Oncology|April 4, 2019
ESMO-MCBS: setting the record straight - Authors' replyYolande Lievens, Riccardo Audisio, Ian Banks, et al.
Acta Oncologica (Stockholm, Sweden)|July 20, 2011
Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumoursJørgen B B Petersen, Yasmin Lassen, Anders T Hansen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 26, 2010
The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 studyCamilla Molich Hoff, Hanne Sand Hansen, Marie Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 7, 2014
Kilovoltage intrafraction motion monitoring and target dose reconstruction for stereotactic volumetric modulated arc therapy of tumors in the liverPer Rugaard Poulsen, Esben S Worm, Jørgen B B Petersen, et al.
Medical Physics|May 6, 2016
Electromagnetic guided couch and multileaf collimator tracking on a TrueBeam acceleratorRune Hansen, Thomas Ravkilde, Esben Schjødt Worm, et al.
Acta Oncologica (Stockholm, Sweden)|September 24, 2015
Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazoleMohamed A Hassan Metwally, Rubina Ali, Maire Kuddu, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2025
Factors associated with participation in a proton therapy clinical trial: a cross-sectional survey of Danish patients with head and neck cancerAnne Wilhøft Kristensen, Kenneth Jensen, Annesofie L Jensen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 6, 2017
Time and dose-related changes in lung perfusion after definitive radiotherapy for NSCLCKatherina P Farr, Azza A Khalil, Ditte S Møller, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2024
Comprehensive insights on the underlying potential and advantage of proton therapy over intensity-modulated photon radiation therapy as highlighted in a wide real world data analysisEster Orlandi, Giulia Fontana, Lisa Licitra, et al.
The Lancet. Oncology|February 5, 2019
Towards an evidence-informed value scale for surgical and radiation oncology: a multi-stakeholder perspectiveYolande Lievens, Riccardo Audisio, Ian Banks, et al.
The Lancet. Oncology|April 4, 2019
ESMO-MCBS: setting the record straight - Authors' replyYolande Lievens, Riccardo Audisio, Ian Banks, et al.
Acta Oncologica (Stockholm, Sweden)|July 20, 2011
Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumoursJørgen B B Petersen, Yasmin Lassen, Anders T Hansen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 26, 2010
The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 studyCamilla Molich Hoff, Hanne Sand Hansen, Marie Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 7, 2014
Kilovoltage intrafraction motion monitoring and target dose reconstruction for stereotactic volumetric modulated arc therapy of tumors in the liverPer Rugaard Poulsen, Esben S Worm, Jørgen B B Petersen, et al.
Medical Physics|May 6, 2016
Electromagnetic guided couch and multileaf collimator tracking on a TrueBeam acceleratorRune Hansen, Thomas Ravkilde, Esben Schjødt Worm, et al.
Acta Oncologica (Stockholm, Sweden)|September 24, 2015
Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazoleMohamed A Hassan Metwally, Rubina Ali, Maire Kuddu, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2025
Factors associated with participation in a proton therapy clinical trial: a cross-sectional survey of Danish patients with head and neck cancerAnne Wilhøft Kristensen, Kenneth Jensen, Annesofie L Jensen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 6, 2017
Time and dose-related changes in lung perfusion after definitive radiotherapy for NSCLCKatherina P Farr, Azza A Khalil, Ditte S Møller, et al.
Pageof 19